We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




PEPFAR and BD Improve African Blood Collection Safety

By LabMedica International staff writers
Posted on 18 Aug 2009
Print article
United States officials have signed a partnership agreement with Becton, Dickinson and Company (BD; Franklin Lakes, NJ, USA), launching an initiative to improve blood collection safety in clinics and hospitals in sub-Saharan Africa. The aim of the pact is to protect healthcare personnel and patients in African countries from infectious agents such as human immunodeficiency virus (HIV) that are transmitted by blood.

A Memorandum of Understanding was signed in Washington on August 11, 2009 by Ambassador Elizabeth Bagley, the U.S. Department of State special representative for global partnerships (Washington DC, USA), and Gary M. Cohen, executive vice president of BD.

Safer blood collection has become critical in sub-Saharan nations and other emerging African countries, which are severely impacted by the HIV/AIDS pandemic. Access to HIV treatment in these countries significantly increased in recent years and consequently has expanded the quantity of blood drawing for HIV screening and monitoring tests.

The three-year initiative--which may be extended up to two additional years--is scheduled to begin in Kenya and expand to include up to four additional U.S. President's Emergency Plan for AIDS Relief (PEPFAR)-supported countries. It will ultimately support in-service training for as many as 10,000 healthcare workers. When fully implemented, the monitoring component of the initiative aims to track as many as two million blood-draws within each participating country.

''The program will help hospital and clinical personnel improve their blood-drawing procedures and specimen handling, processes that are critical to the proper management of HIV/AIDS patients,'' said the State Department (Washington DC, USA) release. In addition, "… [it] will help prevent needle stick injuries by establishing or enhancing needle stick-injury surveillance. These monitoring measures can identify practices that pose risks to health workers and patients.''

Ministries of Health in participating countries will develop individualized policies, guidelines, and standard operating procedures for blood drawing and specimen handling.

Related Links:
U.S. Global Partnership Initiative, the Department of State
Becton, Dickinson and Company
PEPFAR

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Blood Typing System
IH-500 NEXT
New
Vibrio Cholerae O1/O139 Rapid Test
StrongStep Vibrio Cholerae O1/O139 Antigen Combo Rapid Test
New
PSA Test
Human Semen Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.